WMT

122.76

-0.18%↓

COST

985.26

+0.89%↑

142.79

-0.67%↓

75.28

-0.4%↓

163.95

-1.04%↓

WMT

122.76

-0.18%↓

COST

985.26

+0.89%↑

142.79

-0.67%↓

75.28

-0.4%↓

163.95

-1.04%↓

WMT

122.76

-0.18%↓

COST

985.26

+0.89%↑

142.79

-0.67%↓

75.28

-0.4%↓

163.95

-1.04%↓

WMT

122.76

-0.18%↓

COST

985.26

+0.89%↑

142.79

-0.67%↓

75.28

-0.4%↓

163.95

-1.04%↓

WMT

122.76

-0.18%↓

COST

985.26

+0.89%↑

142.79

-0.67%↓

75.28

-0.4%↓

163.95

-1.04%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Atidarymo kaina

16.92 -0.82

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

16.73

Max

17.19

Pagrindiniai rodikliai
By Trading Economics
Pajamos	5.1M -1.6M
Pardavimai	13M 226M
P/E Sektoriaus vid.	29.966 27.787
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-0.705
Darbuotojai	1,570
EBITDA	16M 28M

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-61M 321M
Ankstesnė atidarymo kaina	17.74
Ankstesnė uždarymo kaina	16.92

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-25 20:20; UTC

Įsigijimai, susijungimai, perėmimai

Infosys Agrees to Acquire Stratus

2026-03-25 23:58; UTC

Uždarbis

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

2026-03-25 23:58; UTC

Uždarbis

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

2026-03-25 23:57; UTC

Uždarbis

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

2026-03-25 23:57; UTC

Uždarbis

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

2026-03-25 23:56; UTC

Uždarbis

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

2026-03-25 23:56; UTC

Uždarbis

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

2026-03-25 23:41; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

2026-03-25 23:41; UTC

Uždarbis

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

2026-03-25 23:34; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Declines on Possible Technical Correction -- Market Talk

2026-03-25 22:08; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-25 22:08; UTC

Rinkos pokalbiai

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

2026-03-25 22:07; UTC

Uždarbis

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

2026-03-25 22:07; UTC

Uždarbis

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

2026-03-25 22:07; UTC

Uždarbis

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

2026-03-25 22:07; UTC

Uždarbis

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

2026-03-25 22:07; UTC

Uždarbis

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

2026-03-25 21:58; UTC

Rinkos pokalbiai

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

2026-03-25 21:37; UTC

Rinkos pokalbiai

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

2026-03-25 21:14; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

2026-03-25 21:13; UTC

Įsigijimai, susijungimai, perėmimai

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

2026-03-25 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

2026-03-25 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-25 20:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-25 20:33; UTC

Įsigijimai, susijungimai, perėmimai

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

2026-03-25 20:31; UTC

Uždarbis

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

2026-03-25 20:15; UTC

Įsigijimai, susijungimai, perėmimai

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

2026-03-25 20:15; UTC

Įsigijimai, susijungimai, perėmimai

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

2026-03-25 20:15; UTC

Įsigijimai, susijungimai, perėmimai

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

2026-03-25 20:15; UTC

Įsigijimai, susijungimai, perėmimai

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.